McArdle Laboratory for Cancer Research, University of Wisconsin, Madison, Wisconsin 53706, USA.
Adv Exp Med Biol. 2009;656:85-106. doi: 10.1007/978-1-4419-1145-2_8.
Colon cancer closely follows the paradigm of a single "gatekeeper gene." Mutations inactivating the APC (adenomatous polyposis coli) gene are found in approximately 80% of all human colon tumors and heterozygosity for such mutations produces an autosomal dominant colon cancer predisposition in humans and in murine models. However, this tight association between a single genotype and phenotype belies a complex association of genetic and epigenetic factors that together generate the broad phenotypic spectrum ofboth familial and sporadic colon cancers. In this Chapter, we give a general overview of the structure, function and outstanding issues concerning the role of Apc in human and experimental colon cancer. The availability of increasingly close models for human colon cancer in genetically tractable animal species enables the discovery and eventual molecular identification of genetic modifiers of the Apc-mutant phenotypes, connecting the central role of Apc in colon carcinogenesis to the myriad factors that ultimately determine the course of the disease.
结直肠癌遵循单一“管家基因”模式。APC(结肠腺瘤性息肉病)基因突变失活在所有人类结肠癌中约占 80%,此类突变的杂合性导致人类和鼠类模型中常染色体显性结肠癌易感性。然而,单一基因型与表型之间的这种紧密关联掩盖了遗传和表观遗传因素的复杂关联,这些因素共同产生了家族性和散发性结肠癌的广泛表型谱。在本章中,我们将概述 APC 在人类和实验性结肠癌中的结构、功能和突出问题。在遗传上可处理的动物物种中,越来越接近人类结肠癌的模型的出现使 APC 突变表型的遗传修饰因子的发现和最终分子鉴定成为可能,将 APC 在结肠癌发生中的核心作用与最终决定疾病进程的众多因素联系起来。